Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000175482 | SCV000226966 | pathogenic | not provided | 2014-08-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001220534 | SCV001392529 | pathogenic | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2023-11-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg621Ilefs*2) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). This variant is present in population databases (rs766608755, gnomAD 0.004%). This premature translational stop signal has been observed in individuals with CEP290-related conditions (PMID: 17345604, 27894351). This variant is also known as c.1855-1858delAAAG. ClinVar contains an entry for this variant (Variation ID: 194988). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003468856 | SCV004216669 | pathogenic | Bardet-Biedl syndrome 14 | 2024-03-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001826887 | SCV002094318 | pathogenic | Leber congenital amaurosis | 2021-04-07 | no assertion criteria provided | clinical testing |